[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 962925, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 778700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 591300, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3002, "open": 0.3002, "dayLow": 0.2997, "dayHigh": 0.3148, "regularMarketPreviousClose": 0.3002, "regularMarketOpen": 0.3002, "regularMarketDayLow": 0.2997, "regularMarketDayHigh": 0.3148, "payoutRatio": 0.0, "beta": 1.591, "forwardPE": -0.25603306, "volume": 318893, "regularMarketVolume": 318893, "averageVolume": 5853698, "averageVolume10days": 17302000, "averageDailyVolume10Day": 17302000, "bid": 0.3, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 2536487, "fiftyTwoWeekLow": 0.276, "fiftyTwoWeekHigh": 1.57, "fiftyDayAverage": 0.43344, "twoHundredDayAverage": 0.59069, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5668751, "profitMargins": 0.0, "floatShares": 4746838, "sharesOutstanding": 8187500, "sharesShort": 44391, "sharesShortPriorMonth": 410402, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0054, "heldPercentInsiders": 0.1688, "heldPercentInstitutions": 0.18888001, "shortRatio": 0.01, "shortPercentOfFloat": 0.0055, "impliedSharesOutstanding": 8187500, "bookValue": 1.078, "priceToBook": 0.28738406, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -8701076, "trailingEps": -3.66, "forwardEps": -1.21, "lastSplitFactor": "1:12", "lastSplitDate": 1689638400, "enterpriseToEbitda": 0.613, "52WeekChange": -0.7368421, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 0.3098, "targetHighPrice": 10.0, "targetLowPrice": 1.45, "targetMeanPrice": 4.48333, "targetMedianPrice": 2.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 10306888, "totalCashPerShare": 2.041, "ebitda": -9240397, "totalDebt": 3073733, "quickRatio": 2.967, "currentRatio": 3.022, "debtToEquity": 56.485, "returnOnAssets": -0.44133, "returnOnEquity": -1.35369, "freeCashflow": -5641676, "operatingCashflow": -8844435, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1741393968, "regularMarketTime": 1741381200, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 3.1978726, "regularMarketPrice": 0.3098, "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "cryptoTradeable": false, "postMarketChangePercent": 3.22789, "postMarketPrice": 0.3198, "postMarketChange": 0.00999999, "regularMarketChange": 0.0096000135, "regularMarketDayRange": "0.2997 - 0.3148", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5853698, "fiftyTwoWeekLowChange": 0.033800006, "fiftyTwoWeekLowChangePercent": 0.12246379, "fiftyTwoWeekRange": "0.276 - 1.57", "fiftyTwoWeekHighChange": -1.2602, "fiftyTwoWeekHighChangePercent": -0.8026751, "fiftyTwoWeekChangePercent": -73.68421, "dividendDate": 1571788800, "earningsTimestamp": 1741869000, "earningsTimestampStart": 1741869000, "earningsTimestampEnd": 1741869000, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.66, "epsForward": -1.21, "epsCurrentYear": -2.05, "priceEpsCurrentYear": -0.15112196, "fiftyDayAverageChange": -0.12364, "fiftyDayAverageChangePercent": -0.28525287, "twoHundredDayAverageChange": -0.28089002, "twoHundredDayAverageChangePercent": -0.47552863, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]